Healthcare & Life Sciences News and Articles

Google News – Pharmaceuticals External News

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences - Investing News Network

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT - marketscreener.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Chief medical shake-up at Mirum Pharmaceuticals (NASDAQ: MIRM) includes new leader and exit deal - Stock Titan

news.google.com · 08 Sep 2026

Google News – Clinical Trials External News

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo - ACCESS Newswire

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Can-Fite BioPharma Reports H1 2026 Clinical Progress and Financial Results, Including Promising Survival Data in Pancreatic and Liver Cancer Studies - Quiver Quantitative

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer - Yahoo Finance

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Vor Biopharma (VOR) Completes Enrollment in Phase 3 Trial as Market Eyes Growth Potential - GuruFocus

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer - citybiz

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate - TipRanks

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2% - TradingView

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law - marketscreener.com

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, - GlobeNewswire

news.google.com · 08 Sep 2026

Google News – Biopharma External News

Why Did Quantum BioPharma (CN:TCM) Stock Surge 6.846% on 4 September 2026? - kalkine.ca

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Pharma Eupraxia (Nasdaq: EPRX) moves to Nasdaq's top tier - Stock Titan

news.google.com · 08 Sep 2026

Google News – Pharmaceuticals External News

Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com

news.google.com · 08 Sep 2026

News & Articles

The Frontline Signal: Turning Daily Friction Into Better Healthcare Hiring

The Digital Health Interpreter: Making Technology Usable in Care

The Pitt is up for 25 Emmys - but the show's biggest fans are real-life doctors

From Roster to Resilience: Building a Workforce Risk Register

The Protocol-to-Workflow Specialist: A Career Emerging in Clinical Research

Jury should decide if university’s hiring process was tainted by diversity goals, court rules

Running costs of vaccine damage scheme more than double amount paid to victims

CMS expands TAVR Medicare coverage to asymptomatic patients

Stryker stock falls on slower peripheral vascular, hip sales

Veterans Affairs taps Amwell for telehealth revamp - Healthcare Dive

8 stories on the healthcare affordability crunch

Campaigners hold vigil as stroke unit closes

Epidural Kit Correction: Medical Action Industries Issues Correction for Epidural Kits Containing Spectra Medical Devices Lidocaine Ampules

UK needs new laws for AI in healthcare, says watchdog

Migraines and acne among five more conditions pharmacists can treat

Maternal Mental Health Policy

4 questions about the FDA’s approach to generative AI

Presidential dialogue on high-threat pathogens

5 takeaways from Oura’s IPO filing

Contractors will bear repair costs for lift defects at Queen Mary Hospital, Hong Kong development chief says

NRx Pharmaceuticals to Participate in Upcoming Investor Conferences - Investing News Network

Barclays Upgrades Hikma Pharmaceuticals to Equalweight, Boosts PT - marketscreener.com

Chief medical shake-up at Mirum Pharmaceuticals (NASDAQ: MIRM) includes new leader and exit deal - Stock Titan

Clinical Trial for an Oral Drug to Treat Ebola is Registered in the Pan African Clinical Trials Database and is Ready to Go, As the Largest Ebola Outbreak Continues to Expand in DR Congo - ACCESS Newswire

Can-Fite BioPharma Reports H1 2026 Clinical Progress and Financial Results, Including Promising Survival Data in Pancreatic and Liver Cancer Studies - Quiver Quantitative

Mirum Pharmaceuticals Appoints Dr. Rob Myers as Chief Medical Officer - Yahoo Finance

Vor Biopharma (VOR) Completes Enrollment in Phase 3 Trial as Market Eyes Growth Potential - GuruFocus

Tonix Pharmaceuticals Promotes Thomas Englese to Chief Commercial Officer - citybiz

Hengrui Pharmaceuticals Calls Extraordinary Meeting on New Share Schemes and Buyback Mandate - TipRanks

Fine Foods & Pharmaceuticals H1 EBITDA Adj. €15.2 Mln, EBITDA Margin Adj. At 12.2% - TradingView

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Before September 14, 2026 Deadline - RGRD Law - marketscreener.com

MONDAY REGN INVESTOR DEADLINE: Regeneron Pharmaceuticals, - GlobeNewswire

Why Did Quantum BioPharma (CN:TCM) Stock Surge 6.846% on 4 September 2026? - kalkine.ca

Pharma Eupraxia (Nasdaq: EPRX) moves to Nasdaq's top tier - Stock Titan

Tonix Pharmaceuticals Holding Corp. Announces Appointment of Thomas Englese to Chief Commercial Officer, Effective September 8, 2026 - marketscreener.com